You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
先健科技(01302.HK)获工业大麻种植许可与美资达合作框架
阿思达克 06-05 03:54

先健科技(01302.HK)公布,与美国纳斯达克上市公司索伦托药业达成合作框架协议书,暨双方启动在中国设立深圳云麻工业大麻的合作後,进一步合作在美国设立合资---Scintilla Health以针对亚洲以外的全球市场进行CBD(水溶性大麻二酚)及其他水溶性大麻素产品的研发、生产以及商业化;索伦托药业分别独家排他长期无偿许可深圳云麻在亚洲地区、Scintilla Health在亚洲以外的其他区域,使用其拥有自主知识产权的水溶性配方技术进行水溶大麻素产品的研发、生产和商业化,惟日本区域的商业化安排由双方另行商榷。

同时,公司与索伦托药业合资设立的深圳云麻之控股附属云南麻省已获得种植许可证及加工前置许可,获准开展工业大麻的种植以及筹建工业大麻花叶萃取加工生产线。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account